about
Complex Loci in human and mouse genomesInsulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathyDG-CST (Disease Gene Conserved Sequence Tags), a database of human-mouse conserved elements associated to disease genesAutomated DNA chip annotation tables at IFOM: the importance of synchronisation and cross-referencing of sequence databases.CARPET: a web-based package for the analysis of ChIP-chip and expression tiling data.AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataEvolution of Shc functions from nematode to human.In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging.Genomics of acute myeloid leukemia: the next generation.The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.Myc-binding-site recognition in the human genome is determined by chromatin context.Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repairPML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.The genomic and epigenomic landscapes of AML.RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.The PML gene is not involved in the regulation of MHC class I expression in human cell lines.The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.Genome-wide mapping of human DNA-replication origins: levels of transcription at ORC1 sites regulate origin selection and replication timing.Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.PREP1 tumor suppressor protects the late-replicating DNA by controlling its replication timing and symmetry.Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial ApoptosisAbstract A28: Challenging new epigenetic vulnerabilities in human metastatic melanoma PDXsSHC1 (SHC (Src homology 2 domain containing) transforming protein 1)Melanoma: targeting signaling pathways and RaLPA new member of the Shc family, RaLP, is involved in the melanoma apoptotic pathwaysImmunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaAcute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenanceAcute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repairAdenosine triphosphate catabolism in bovine spermatozoaEffects of adenine nucleotides on low Km 5′ nucleotidase from human seminal plasmap53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic ValueRelease of paused RNA polymerase II at specific loci favors DNA double-strand-break formation and promotes cancer translocationsDevelopment of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs
P50
Q21145268-F209E62D-4C6D-4D89-9309-61F341CBED66Q24338974-20E65E0C-60E9-4B9B-B115-83EE28A9D8F1Q24793058-DA0FF43F-88C1-457E-9CE4-DFDA3656F19CQ33202704-C90A6B76-0BB6-4A18-8BA8-26C1ACCA0BAEQ33378855-986681E1-52E4-4992-8682-D521CB42DD52Q33388188-64F61F5E-6B60-45A0-AC2F-DC07DFCB3FA1Q33411772-628E101A-E654-48C2-9F14-F75801E6340DQ33750026-3ABA3BC1-80E6-45FD-B3C8-3D5E13E781D0Q34087836-7DE815AD-F433-4544-B8B7-4D57D4E5A5F1Q36017883-E9B7B88B-FEEA-4AAD-BCC5-6F6667C2043BQ37005075-94840BF8-B26B-426A-AECE-FB616981E279Q38016170-8C629853-D29F-4145-8EA4-25921F3D8BA5Q38286872-BBF370C2-3295-4B30-9C23-F06B02882D7DQ38312447-36316986-5F27-4932-BBE7-944A4D982259Q38347126-A90A1AFB-25E1-4E2F-8AF4-66E9E212D004Q38438690-9FFB521F-98B1-4D8F-A612-0F04A139DAD9Q38588931-D6B69FB3-2EA8-45E8-9995-F9CC75A909D7Q39113922-FF3690B0-E066-48EC-9D59-907A1500C19FQ40149382-891D8833-34C0-443E-9334-07BBF676CE8CQ40680243-B309DFD1-44B6-40F4-AC97-0FA65614B2EFQ40738889-74EEC835-9EE0-4A29-94B4-133A02B3E53AQ41868711-A95F3F83-B29E-441B-81D6-EB51F4531F59Q42804288-8295990E-3358-408C-8429-B9F5AC4B9F16Q42959276-440D683C-4E54-481F-B7C7-6EADDE4004FEQ49912515-36FFD9C2-51FD-436C-ADEC-8098AACBA3F5Q58454329-9BA1EFD1-1ED1-4A8C-BC98-2F080C568D85Q58882368-FD83FFB1-3BB5-468A-A515-6F5C9EA23F8CQ58882371-472836DA-9A11-4C3E-9CF0-1857E21F9051Q58882374-D2FB7B9A-0B8E-4B4D-AD29-91AFAB16A678Q58882376-7DA77C65-A314-4587-8462-7012DF91F0FEQ58882378-F7E26143-1C40-4B01-8119-33C98C8E4124Q58882381-AD0F3E03-A48D-4F94-B0B8-BCE9604FDA75Q58882386-968F26BD-4BB0-4DDD-AA5C-2DB4B813176BQ58882388-2D60D49C-0EE4-46E6-AEBC-E509A006DD00Q58882390-F6EA4C8C-0194-4B95-8B8D-7C7595E0DEF6Q60907996-CC20050B-D3DB-42BA-85CF-A6B65AB0C246Q64386891-1A27619E-DD50-4A3E-BF2F-04E910053C09Q92879104-4EF49CA9-02F6-4F4B-8A7F-AEC6309A0D31
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lucilla Luzi
@ast
Lucilla Luzi
@en
Lucilla Luzi
@es
Lucilla Luzi
@nl
type
label
Lucilla Luzi
@ast
Lucilla Luzi
@en
Lucilla Luzi
@es
Lucilla Luzi
@nl
prefLabel
Lucilla Luzi
@ast
Lucilla Luzi
@en
Lucilla Luzi
@es
Lucilla Luzi
@nl
P106
P21
P31
P496
0000-0002-8746-4179